Clinical Trial Update: Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vinflunine in locally advanced or metastatic urothelial carcinoma of the urothelium (bladder cancer); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Renal Cell Carcinoma
• Transitional Cell Carcinoma
• Urothelial Carcinoma
• Urothelial Carcinoma of the Renal Pelvis
• Urothelial Carcinoma of the Ureter

Drugs mentioned

• Vinflunine (vinflunine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Transitional Cell Carcinoma, Bladder Neoplasms | Phase 2 | Status: COMPLETED